BIOMAT Database Logo BIOMAT Database Logo

Inhibition of human neutrophil elastase with peptidyl electrophilic ketones. 2. Orally active PG-Val-Pro-Val pentafluoroethyl ketones. 1994

M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Marion Merrell Dow Research Institute, Cincinnati, Ohio 45215.

Valylprolyvalyl pentafluoroethyl ketones with different N-protecting groups were evaluated in vitro and in vivo as inhibitors of human neutrophil elastase (HNE). Several of these compounds were found to be orally active in HNE-induced rat and hamster lung hemorrhage models. The compound with 4-(4-morpholinylcarbonyl)benzoyl as the protecting group, 71 (MDL 101,146), was studied in greater detail. Hydration and epimerization studies were performed on 71 and related compounds in various media, including human blood serum. High-performance liquid chromatography studies on a reversed-phase system as a measure of the lipophilicity of 71 and related compounds revealed a small range of relative retention times wherein the orally active compounds fell. The Ki value determined for 71 vs HNE was 25 nM.

UI MeSH Term Description Entries
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010196 Pancreatic Elastase A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36. Elastase,Pancreatopeptidase,Elastase I,Pancreatic Elastase I,Elastase I, Pancreatic,Elastase, Pancreatic
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones.
July 1998, Journal of medicinal chemistry,
M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Pharmacological evaluation of selected, orally active, peptidyl inhibitors of human neutrophil elastase.
December 1995, The Journal of pharmacology and experimental therapeutics,
M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Discovery and biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of human neutrophil elastase.
June 1997, Journal of medicinal chemistry,
M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactams.
January 2001, Bioorganic & medicinal chemistry letters,
M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Inhibition of human neutrophil elastase. 3. An orally active enol acetate prodrug.
January 1995, Journal of medicinal chemistry,
M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Synthesis of peptidyl fluoromethyl ketones and peptidyl alpha-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin G.
January 1990, Journal of medicinal chemistry,
M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones.
February 1992, Journal of medicinal chemistry,
M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Development of orally active nonpeptidic inhibitors of human neutrophil elastase.
April 2001, Journal of medicinal chemistry,
M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Design and synthesis of new orally active inhibitors of human neutrophil elastase.
May 2001, Bioorganic & medicinal chemistry,
M R Angelastro, and L E Baugh, and P Bey, and J P Burkhart, and T M Chen, and S L Durham, and C M Hare, and E W Huber, and M J Janusz, and J R Koehl
Inhibition of human pancreatic elastase 2 by peptide chloromethyl ketones.
July 1980, Biochimica et biophysica acta,
Copied contents to your clipboard!